Page 25 - Vaccine

Govt okays Bharat Biotech's Ankleshwar plant to produce Covaxin: Minister

Union minister Mansukh Mandaviya on Tuesday said the government has given approval to Bharat Biotech's Ankleshwar-based manufacturing plant to produce COVID-19 vaccine Covaxin. "Govt of India approves vaccine manufacturing facility for production of @BharatBiotech's #Covaxin in Ankleshwar, Gujarat," Mandaviya tweeted. The approval would help increase availability of COVID-19 vaccines in the country, he added. "Following PM @NarendraModi ji's vision of #SabkoVaccineMuftVaccine, this will increase vaccine availability & accelerate the world's largest vaccine drive," the minister who heads both Chemicals and Fertilisers and Health ministries noted. In May this year, Bharat Biotech had announced that it plans to produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility. The Hyderabad-based firm had noted that it would utilise the manufacturing plant of its wholly-owned unit - Chiron Behring, to add another 200 million doses of Covaxin.

DRL seeks a booster from Sputnik V but hurdles in scaling up remain

Even as the company investigates complaints of malpractice in the Ukraine, hurdles in scaling up the Russian vaccine remain the bigger challenge in the near term

J&J seeks approval for single-dose Covid-19 vaccine in India

It is not clear whether J&J is seeking indemnity against adverse events following vaccination like its US peers

China pledges 2 billion Covid-19 vaccines globally through year's end

Xi Jinping pledged 2 billion doses of Chinese vaccines would be supplied to the world through this year, an increase that would add to country's efforts as the largest global exporter of vaccines

Novavax seeks OK for emergency use of Covid vaccine in India, Indonesia

Vaccine maker Novavax announced Thursday it has asked regulators in India, Indonesia and the Philippines to allow emergency use of its Covid-19 vaccine

Moderna Covid-19 vaccine tallies more than $4 billion in Q2 sales

Moderna's Covid-19 vaccine brought in more than $4 billion in second-quarter sales, helping to push the vaccine developer into a profit

Are coronavirus vaccines working? What the real world tells us

Delta, the strain first reported in India in October, is the most worrisome detected so far

Serum Institute may start Covid-19 vaccine trials on kids in August

SII will conduct trials on those aged between two to 17 years

Sanofi to buy partner Translate Bio for $3.2 billion in mRNA push

Sanofi has lagged behind upstarts BioNTech SE and Moderna Inc. in the pandemic as they raced ahead with mRNA shots that have now been injected into arms more than a billion times

Gennova to use mRNA tech to develop vaccines for Zika, tuberculosis

mRNA vaccines typically have stringent temperature requirements to remain stable

Astra's Covid-19 vaccine sales triple in Q2, top $1 billion in H1

Firm exploring whether vaccine biz is sustainable for next 5-10 years: Official

Improving vaccine distribution

Private sector channel needs to be reworked

Over 10,000 Covid vaccines administered in Delhi on Sunday: Cowin portal

The city has administered over 96 lakh doses, including 23,84,076 second doses

No domestic vaccine maker has sought indemnity: Junior Health Minister

Bharti Pravin Pawar says Centre has set up team to deal with various issues related to procurement of Covid-19 vaccine from foreign firms

India Coronavirus Dispatch: 'Symbolic snan' in Haridwar on Guru Purnima

Study finds immune response to Covid vaccine found linked to age, azithromycin out of favour as therapy, and more-news relevant to India's fight against the pandemic

EU is donating more than 200 million doses of vaccines by end of year

The European Union announced on Thursday that it will donate more than 200 million doses of vaccines against Covid-19 to countries with average and low incomes before the end of this year

Russia in talks with Kerala govt for Sputnik V plant, says state minister

Kerala State Industrial Development Corporation (KSIDC) to scout for land, prepare draft

NEGVAC in talks with offshore manufacturers for import of Covid jabs: Govt

In a written reply to a question in the Rajya Sabha, MoS for Health Bharati Pravin Pawar said as on July 16, a total of 2.61 lakh doses of the Sputnik V vaccine have been administered in the country

TechInvention ties up with Korean co to bring oral cholera vaccine to India

Clinical trials of WHO pre-qualified vaccine to start soon; Unicef price is $2 per dose, private market price globally is $8-10; Initial volumes to be imported; India would need 83 mn doses a year

Over 400 million coronavirus vaccine doses administered in country: Govt

More than 46.38 lakh (46,38,106) vaccine doses were administered on Saturday, the report said